Persistence of tolvaptan medication for autosomal dominant polycystic kidney disease: A retrospective cohort study using Shizuoka Kokuho Database

Autosomal dominant polycystic kidney disease (ADPKD) is a rare hereditary disease leading to end-stage renal failure in approximately half of patients by seventy years of age. It is important to continuously take tolvaptan to control disease progression. However, adherence to tolvaptan in a real-wor...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Ryuta, Yamamoto, Hiroyuki, Ichihara, Nao, Kumamaru, Hiraku, Nishimura, Shiori, Shimada, Koki, Mori, Kiyoshi, Miyachi, Yoshiki, Miyata, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542978/
https://www.ncbi.nlm.nih.gov/pubmed/36221375
http://dx.doi.org/10.1097/MD.0000000000030923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542978/
https://www.ncbi.nlm.nih.gov/pubmed/36221375
http://dx.doi.org/10.1097/MD.0000000000030923

Ejemplares similares